Skip to main content
Top
Published in: Acta Neurologica Belgica 3/2019

01-09-2019 | Letter to the Editor

Late onset necrotizing autoimmune myopathy 1 year after cessation of statin treatment

Authors: Maryam Balke, Anna Brunn, Kristl G. Claeys, Gereon R. Fink, Gilbert Wunderlich

Published in: Acta Neurologica Belgica | Issue 3/2019

Login to get access

Excerpt

https://static-content.springer.com/image/art%3A10.1007%2Fs13760-018-0985-x/MediaObjects/13760_2018_985_Fig1_HTML.gif
Fig. 1

Necrotizing myopathy of the rectus femoris muscle. a Increased muscle fiber caliber spectrum with hypertrophic (black asterisk), partly atrophic (arrows) as well as atrophic muscle fibers (arrow head), and a single necrotic muscle fiber with early signs of myophagia (white asterisk) as indicated by two macrophages in the sarcoplasm of the necrotic muscle fiber. H&E staining; original magnification × 400. b Enzyme histochemistry with acid phosphatase depicts the necrotic muscle fiber with a myophagic reaction but no further endomysial inflammatory infiltrates; original magnification × 400. c In the endomysial tissue, there are only single T-cells which do not invade unaffected muscle fibers. Immunohistochemistry with monoclonal rabbit anti-human CD3 (DCS, Hamburg, Germany) and slight counterstaining with hemalum; original magnification × 200. d Endomysial inflammatory infiltrates are dominated by macrophages and numerous macrophages phagocytize necrotic muscle fibers. Immunohistochemistry with monoclonal mouse anti-human CD68 (DCS) and slight counterstaining with hemalum; original magnification × 200. e Note the focally weak and heterogeneous sarcolemmal upregulation of MHC class I antigen (arrows). Immunohistochemistry with monoclonal mouse anti-human MHC class I antigen (Dako, Hamburg, Germany) and slight counterstaining with hemalum; original magnification × 200. f A necrotic muscle fiber expresses the membrane attack complex C5b-9 in the sarcoplasm (arrow). Immunohistochemistry with monoclonal mouse anti-human C5b-9 (Dako) and slight counterstaining with hemalum; original magnification × 200

Literature
  1. Nazir S, Lohani S, Tachamo N, Poudel D, Donato A (2017) Statin-associated autoimmune myopathy: a systematic review of 100 cases. J Clin Rheumatol 23:149–154View ArticlePubMed
  2. Carroll MB, Newkirk MR, Sumner NS (2016) Necrotizing autoimmune myopathy: a unique subset of idiopathic inflammatory myopathy. J Clin Rheumatol Pract Rep Rheum Musculoscelet Dis 22:376–380
  3. Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL (2010) A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 62:2757–2766View ArticlePubMedPubMed Central
  4. Argov Z (2015) Statins and the neuromuscular system: a neurologist’s perspective. Eur J Neurol 22:31–36View ArticlePubMed
  5. Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F et al (2014) French myositis network: anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltim) 93:150–157View Article
Metadata
Title
Late onset necrotizing autoimmune myopathy 1 year after cessation of statin treatment
Authors
Maryam Balke
Anna Brunn
Kristl G. Claeys
Gereon R. Fink
Gilbert Wunderlich
Publication date
01-09-2019
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica / Issue 3/2019
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-018-0985-x

Other articles of this Issue 3/2019

Acta Neurologica Belgica 3/2019 Go to the issue

Neuro-Images

Nine syndrome